시장보고서
상품코드
2057561

의료기기용 재조합 단백질 기반 바이오소재 시장 보고서 : 기회 및 전략(2035년)

Recombinant Protein-Based Biomaterials Market For Medical Devices Global Market Opportunities And Strategies To 2035

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 506 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,867,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,927,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 12,986,000
※ 부가세 별도
한글목차
영문목차

세계의 의료기기용 재조합 단백질 기반 바이오소재 시장 규모는 2020년에 2억 730만 달러로 평가되었고, 2025년까지 연평균 복합 성장률(CAGR) 15.00% 이상으로 성장했습니다.

의료기기용 재조합 단백질 기반 바이오소재 시장이란, 재조합 DNA 기술을 이용해 제조된 생체 재료에 초점을 맞춘 의료재료 산업 한 분야를 가리킵니다. 이러한 바이오소재는 콜라겐, 에라스틴, 실크, 피브린, 젤라틴등이 인공적으로 설계된 단백질이며, 의료기기에서의 사용에 임하여 높은 순도, 균일성 및 생체 적합성을 확보하기 위해(때문에), 관리된 생물학적 시스템내에서 제조됩니다. 의료기기 재조합 단백질 기반 바이오소재 주요 목적은 안전성, 성능 및 생체에의 통합성을 높이는 것에 있습니다.

의료기기용 재조합 단백질 기반 바이오소재 시장은 초기 연구개발 및 시제품 제작부터 규제 당국의 승인, 제조, 환자 치료까지 의료기기 개발 및 임상 적용의 전 과정에서 사용되는 의료기기용 재조합 단백질 기반 바이오소재에 대한 사업체(조직, 개인사업자, 파트너십)의 매출로 구성됩니다.

복잡하고 치유하기 어려운 상처 발생률 증가

과거 의료기기용 재조합 단백질 기반 바이오소재 시장은 복잡하고 치유하기 어려운 상처의 발생률 증가로 인해 크게 성장했습니다. 당뇨병, 혈관 기능 부전, 노화에 따른 동반 질환과 같은 만성 질환의 유병률이 전 세계적으로 증가함에 따라 의료 시스템은 기존 치료법으로 치유하기 어려운 상처의 부담이 증가함에 따라 조직 재생과 치유를 촉진하는 첨단 상처 관리 솔루션에 대한 수요가 증가하고 있습니다. 예를 들어, 2022년 11월 영국의 상처 관리 교육 및 모범 사례 조직인 Wounds UK가 발표한 임상 지침에 따르면, 지역 의료 및 급성기 의료 현장에서 임상의를 지원하는 영국의 상처 관리 교육 및 모범 사례 조직인 Wounds UK는 치유하기 어려운 상처가 상처 관리 과정의 주요하고 지속적인 과제로 확인되었습니다. 또한, 표준적인 치료 개입에도 불구하고 전체 상처의 약 30%가 치유가 어려운 상처로 분류된다는 증거도 있습니다. 보고서는 또한 당뇨병성 족부궤양, 정맥성 하지궤양, 욕창 등 치유가 어려운 상처가 의료 자원 이용에 있어 불균형적인 비율을 차지하고 있으며, 이는 지역 의료 시스템에서 치료 기간의 장기화, 치료의 복잡성, 그리고 전반적인 치료 비용 증가에 기여하고 있다고 지적하고 있습니다. 따라서 의료기기 시장에서 재조합 단백질 기반 바이오소재 시장은 과거 복잡하고 치유하기 어려운 상처의 발생률이 증가함에 따라 크게 견인되었습니다.

임상용 바이오소재 솔루션을 지원하는 재조합 콜라겐 플랫폼 도입, 임상급 생체재료 솔루션 지원

의료기기용 재조합 단백질 기반 바이오소재 시장에서 활동하는 주요 기업들은 생물학적 성능, 규제 대응력, 제조 일관성, 첨단 치료 및 이식 용도를 지원하는 임상 적용 가능한 재조합 콜라겐 플랫폼을 도입하는 데 점점 더 많은 노력을 기울이고 있습니다. 임상 적용 가능한 재조합 콜라겐 플랫폼의 도입에 점점 더 집중하고 있습니다. 이러한 재조합 콜라겐 소재는 정밀한 바이오 발효 기술을 통해 설계되어 천연 인체 콜라겐 구조를 충실하게 모방하여 리퍼비쉬 의료기기 및 조직 복구 제품에 통합될 때 세포와의 상호 작용을 강화하고, 면역원성을 낮추며, 예측 가능한 분해 프로파일을 제공합니다. 예를 들어, 2025년 9월 독일에 본사를 둔 특수 화학 및 바이오 소재 제조업체인 에보닉 인더스트리즈(Evonik Industries)는 임상시험용으로 '베콜란(Vecollan)' 재조합 콜라겐을 출시했습니다. 이 플랫폼은 상처 치유, 연조직 재건 및 기타 의료기기 용도 분야의 임상시험에 적합한 일관된 고순도 콜라겐을 제공하도록 설계된 플랫폼입니다. 베콜란 재조합 콜라겐은 로트 간 재현성을 보장하고 임상 등급 품질 기준에 따라 제어된 발효 공정을 통해 제조되어 연구부터 임상 평가로의 전환을 가속화할 수 있도록 지원합니다.

의료기기용 세계 재조합 단백질 기반 바이오소재 시장은 세분화되어 있으며, 다수의 소규모 업체들이 시장에서 활동하고 있습니다. 2024년 기준, 시장 상위 10개 주요 기업이 전체 시장의 8.84%를 점유했습니다.

자주 묻는 질문

  • 의료기기용 재조합 단백질 기반 바이오소재 시장 규모는 어떻게 되나요?
  • 의료기기용 재조합 단백질 기반 바이오소재의 주요 목적은 무엇인가요?
  • 의료기기용 재조합 단백질 기반 바이오소재 시장의 성장 요인은 무엇인가요?
  • 의료기기용 재조합 단백질 기반 바이오소재 시장에서 활동하는 주요 기업들은 어떤 노력을 하고 있나요?
  • 의료기기용 재조합 단백질 기반 바이오소재 시장의 주요 기업들은 어떤 제품을 출시했나요?
  • 의료기기용 재조합 단백질 기반 바이오소재 시장의 경쟁 구도는 어떤가요?

목차

제1장 주요 요약

제2장 목차

제3장 표 리스트

제4장 그래프 리스트

제5장 보고서 구성

제6장 시장 특징

제7장 의료기기용 재조합 단백질 기반 바이오소재 시장 : 공급망 분석

제8장 주요 시장 동향

제9장 세계의 의료기기용 재조합 단백질 기반 바이오소재 : 성장 분석 및 전략적 분석 프레임워크

제10장 의료기기용 재조합 단백질 기반 바이오소재 시장 : 거시경제 상황 개요

제11장 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향

제12장 세계의 의료기기용 재조합 단백질 기반 바이오소재 시장 : 규모 및 성장 분석

제13장 세계의 의료기기용 재조합 단백질 기반 바이오소재 시장 : 총잠재 시장(TAM) 분석

제14장 세계의 의료기기용 재조합 단백질 기반 바이오소재 시장 : 시장 세분화

제15장 의료기기용 재조합 단백질 기반 바이오소재 시장 : 지역별 및 국가별 분석

제16장 아시아태평양 시장

제17장 동남아시아 시장

제18장 북미 시장

제19장 서유럽 시장

제20장 남미 시장

제21장 동유럽 시장

제22장 중동 시장

제23장 아프리카 시장

제24장 경쟁 구도 및 기업 개요

제25장 기타 주요 기업 및 혁신 기업

제26장 경쟁 대시보드

제27장 의료기기용 재조합 단백질 기반 바이오소재 시장 : 기업 평가 매트릭스

제28장 의료기기용 재조합 단백질 기반 바이오소재 시장 : 신흥 스타트업

제29장 주요 인수합병(M&A)

제30장 최근 동향 : 의료기기용 재조합 단백질 기반 바이오소재 시장

제31장 기회와 전략

제32장 의료기기용 재조합 단백질 기반 바이오소재 시장 : 결론과 제안

제33장 부록

AJY

The recombinant protein-based biomaterials market for medical devices refers to the segment of the medical materials industry focused on biomaterials produced using recombinant DNA technology. These biomaterials are engineered proteins, such as collagen, elastin, silk, fibrin, and gelatin, manufactured in controlled biological systems to ensure high purity, consistency, and biocompatibility for use in medical devices. The primary purpose of recombinant protein-based biomaterials in medical devices is to enhance safety, performance, and biological integration.

The recombinant protein-based biomaterials market for medical devices market consists of sales by entities (organizations, sole traders and partnerships) of recombinant protein-based biomaterials market for medical devices that are used throughout the lifecycle of medical device development and clinical application from early research and prototyping through regulatory approval, production, and patient care

The global recombinant protein-based biomaterials market for medical devices market was valued at $207.3 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 15.00%.

Increasing Incidence Of Complex And Non-Healing Wounds

During the historic period, the recombinant protein-based biomaterials market for medical devices market was significantly driven by the increasing incidence of complex and non-healing wounds. As the prevalence of chronic health conditions such as diabetes, vascular insufficiencies, and aging-related comorbidities rose globally, healthcare systems experienced a growing burden of wounds that were difficult to heal using conventional treatments, creating demand for advanced wound care solutions that support tissue regeneration and accelerated healing. For instance, in November 2022, according to clinical guidance published by Wounds UK, a UK-based wound care education and best-practice organization supporting clinicians in community and acute care settings, non-healing wounds were identified as a major and persistent challenge within wound management pathways, with evidence indicating that approximately 30% of all wounds are classified as non-healing, despite standard care interventions. The source further noted that non-healing wounds, including diabetic foot ulcers, venous leg ulcers, and pressure injuries, account for a disproportionate share of healthcare resource utilization, contributing to prolonged treatment durations, increased care complexity, and significantly higher overall treatment costs within community healthcare systems. Therefore, the recombinant protein-based biomaterials market for medical devices market was significantly driven by the increasing incidence of complex and non-healing wounds during the historic period.

Introduction Of Recombinant Collagen Platforms To Support Clinical-Grade Biomaterial Solutions

Major companies operating in the recombinant protein-based biomaterials market for medical devices are increasingly focusing on the introduction of clinically enabled recombinant collagen platforms that support advanced therapeutic and implantable applications with improved biological performance, regulatory readiness, and manufacturing consistency. These recombinant collagen materials are engineered using precision biofermentation techniques to closely mimic native human collagen structures, enabling enhanced cell interaction, reduced immunogenicity, and predictable degradation profiles when incorporated into regenerative medical devices and tissue repair products. For instance, in September 2025, Evonik Industries, a Germany-based specialty chemicals and biomaterials manufacturer, launched Vecollan recombinant collagen for use in clinical studies, a platform designed to deliver consistent, high-purity collagen suitable for investigational applications in wound healing, soft tissue reconstruction, and other medical device contexts. Vecollan recombinant collagen is produced through controlled fermentation processes that ensure lot-to-lot reproducibility and comply with clinical-grade quality standards, supporting accelerated translation from research to clinical evaluation.

The global recombinant protein-based biomaterials market for medical devices market is fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 8.84% of the total market in 2024.

Recombinant Protein-Based Biomaterials Market For Medical Devices Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global recombinant protein-based biomaterials market for medical devices market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for recombinant protein-based biomaterials market for medical devices ? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The recombinant protein-based biomaterials market for medical devices market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider recombinant protein-based biomaterials market for medical devices market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
  • Key Trends Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
  • Market Segmentation Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by recombinant protein material type, by material form and by processing & manufacturing technology in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations This section includes recommendations for recombinant protein-based biomaterials market for medical devices providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Markets Covered:

  • 1) By Recombinant Protein Material Type: Recombinant Collagen; Recombinant Silk Proteins; Recombinant Elastin/ Elastin-Like Polypeptides (ELPs); Recombinant Gelatin; Recombinant Keratin; Other Recombinant Protein Material Types
  • 2) By Material Form: Films And Membranes; Fibers And Nonwovens; Foams And Sponges; Hydrogels; Solid Molded Parts; Coatings; Other Material Forms
  • 3) By Processing And Manufacturing Technology: Injection Molding; Compression Molding; Extrusion; Solvent Casting; Electrospinning; Freeze Drying; 3D Printing/Biofabrication; Cross Linking And Curing Technologies; Other Processing & Manufacturing Technologies
  • 4) By Application: Implantable Medical Devices; Wound Care Materials; Tissue Scaffolds; Drug-Device Combination Materials; Other Applications

Companies HTL Biotechnology; Jellagen Ltd.; 3D BioFibR Inc.; Creative Biomart Inc.; Collagen Solutions Plc.

  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; recombinant protein-based biomaterials market for medical devices indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Dashboard

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Recombinant Protein-Based Biomaterials Market For Medical Devices Market Definition And Segmentations
  • 6.4 Market Segmentation By Recombinant Protein Material Type (Recombinant Collagen, Recombinant Silk Proteins, Recombinant Elastin/ Elastin-Like Polypeptides (ELPs), Recombinant Gelatin, Recombinant Keratin And Other Recombinant Protein Material Types)
  • 6.5 Market Segmentation By Material Form (Films And Membranes, Fibers And Nonwovens, Foams And Sponges, Hydrogels, Solid Molded Parts, Coatings And Other Material Forms)
  • 6.6 Market Segmentation By Processing And Manufacturing Technology (Injection Molding, Compression Molding, Extrusion, Solvent Casting, Electospinning, Freeze Drying, 3D Printing/ Biofabrication, Crosslinking & Curing Technologies and Other Processing & Manufacturing Technologies)
  • 6.7 Market Segmentation By Application (Implantable Medical Devices, Wound Care Materials, Tissue Scaffolds, Drug-Device Combination Materials And Other Applications)
  • 6.8 Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Overview Of Key Products
  • 6.9 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market Attractiveness Scoring And Analysis
    • 6.9.1 Overview Of Market Attractiveness Framework
    • 6.9.2 Quantitative Scoring Methodology
    • 6.9.3 Market Attractiveness Scoring And Interpretation
    • 6.9.4 Factor-Wise Evaluation
    • 6.9.5 Strategic Implications And Recommendations

7 Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Supply Chain Analysis

  • 7.1 Overview of the Supply Chain and Ecosystem
    • 7.1.1 Resources
    • 7.1.2 Manufacturers
    • 7.1.3 Distribution
    • 7.1.4 End Users

8 Major Market Trends

  • 8.1 Key Technologies & Future Trends
    • 8.1.1 Industry 4.0 And Intelligent Manufacturing
    • 8.1.2 Sustainability, Climate Tech And Circular Economy
    • 8.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 8.1.4 Artificial Intelligence And Autonomous Intelligence
    • 8.1.5 Biotechnology, Genomics And Precision Medicine
  • 8.2 Major Trends
    • 8.2.1 Introduction Of Recombinant Collagen Platforms To Support Clinical-Grade Biomaterial Solutions
    • 8.2.2 Expansion Of Ancient Collagen-Derived Extracellular Matrix Platforms
    • 8.2.3 Strategic Collaborations To Engineer Enhanced Structural Proteins For Medical Biomaterials

9 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Growth Analysis And Strategic Analysis Framework

  • 9.1 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market PESTEL Analysis
    • 9.1.1 Political
    • 9.1.2 Economic
    • 9.1.3 Social
    • 9.1.4 Technological
    • 9.1.5 Environmental
    • 9.1.6 Legal
  • 9.2 Analysis Of End Users
    • 9.2.1 Biopharmaceutical companies
    • 9.2.2 Research laboratories
    • 9.2.3 Academic institutes
    • 9.2.4 Contract research organizations

10 Recombinant Protein-Based Biomaterials Market For Medical Devices Market - Macro Economic Scenario

  • 10.1 Impact of Interest Rate Fluctuations
  • 10.2 Impact of Inflationary Pressures
  • 10.3 Impact of Geopolitical Dynamics on API Supply Chains
  • 10.4 Impact of the COVID-19 Pandemic and Recovery
  • 10.5 Strategic Insights and Future Outlook

11 Supply Chain Impact from Tariff War and Trade Protectionism

12 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market Size And Growth Analysis

  • 12.1 Historic Market Growth, 2020 - 2025, Value ($ Million)
    • 12.1.1 Market Drivers 2020 - 2025
    • 12.1.2 Market Restraints 2020 - 2025
  • 12.2 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
  • 12.3 Forecast Growth Contributors/Factors
    • 12.3.1 Quantitative Growth Contributors
    • 12.3.2 Drivers
    • 12.3.3 Restraints

13 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Total Addressable Market (TAM) Analysis

  • 13.1 Definition And Scope of Total Addressable Market (TAM)
  • 13.2 Methodology And Assumptions
    • 13.2.1 Total Addressable Market for the Recombinant Protein-Based Biomaterials Market For Medical Devices Market - Business to Customer (B2C)
    • 13.2.2 TAM Comparison Analysis
    • 13.2.3 TAM vs Market Size Comparison

14 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market Segmentation

  • 14.1 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.2 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.3 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.4 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Regional and Country Analysis

  • 15.1 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.2 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Asia-Pacific Market

  • 16.1 Asia-Pacific Market Summary
  • 16.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 16.3 Asia-Pacific Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.4 Asia-Pacific Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.5 Asia-Pacific Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.6 Asia-Pacific Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.7 China Market
    • 16.7.1 China Market Summary
    • 16.7.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 16.7.3 China Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.7.4 China Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.7.5 China Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.7.6 China Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.8 India Market
    • 16.8.1 India Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.8.2 India Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.8.3 India Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.8.4 India Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.9 Japan Market
    • 16.9.1 Japan Market Summary
    • 16.9.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 16.9.3 Japan Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.9.4 Japan Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.9.5 Japan Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.9.6 Japan Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.10 Australia Market
    • 16.10.1 Australia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.10.2 Australia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.10.3 Australia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.10.4 Australia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.11 South Korea Market
    • 16.11.1 South Korea Market Summary
    • 16.11.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 16.11.3 South Korea Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.11.4 South Korea Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.11.5 South Korea Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.11.6 South Korea Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.12 Taiwan Market
  • 16.13 Taiwan Market Summary
    • 16.13.1 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 16.13.2 Taiwan Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.13.3 Taiwan Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.13.4 Taiwan Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.13.5 Taiwan Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 South East Asia Market

  • 17.1 South East Asia Market Summary
  • 17.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.3 South East Asia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.4 South East Asia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.5 South East Asia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6 South East Asia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7 Indonesia Market
    • 17.7.1 Indonesia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.7.2 Indonesia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.7.3 Indonesia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.7.4 Indonesia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 North America Market

  • 18.1 North America Market Summary
  • 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 18.3 North America Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.4 North America Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.5 North America Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6 North America Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.7 USA Market
    • 18.7.1 USA Market Summary
    • 18.7.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 18.7.3 USA Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 18.7.4 USA Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 18.7.5 USA Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 18.7.6 USA Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.8 Canada Market
    • 18.8.1 Canada Market Summary
    • 18.8.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 18.8.3 Canada Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 18.8.4 Canada Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 18.8.5 Canada Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 18.8.6 Canada Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 Western Europe Market

  • 19.1 Western Europe Market Summary
  • 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 19.3 Western Europe Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.4 Western Europe Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.5 Western Europe Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.6 Western Europe Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.7 UK Market
    • 19.7.1 UK Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.7.2 UK Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.7.3 UK Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.7.4 UK Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.8 Germany Market
    • 19.8.1 Germany Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.8.2 Germany Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.8.3 Germany Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.8.4 Germany Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.9 France Market
    • 19.9.1 France Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.9.2 France Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.9.3 France Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.9.4 France Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.10 Italy Market
    • 19.10.1 Italy Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.10.2 Italy Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.10.3 Italy Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.10.4 Italy Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.11 Spain Market
    • 19.11.1 Spain Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.11.2 Spain Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.11.3 Spain Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.11.4 Spain Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 South America Market

  • 20.1 South America Market Summary
  • 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 20.3 South America Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.4 South America Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.5 South America Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.6 South America Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.7 Brazil Market
    • 20.7.1 Brazil Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 20.7.2 Brazil Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 20.7.3 Brazil Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 20.7.4 Brazil Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 Eastern Europe Market

  • 21.1 Eastern Europe Market Summary
  • 21.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 21.3 Eastern Europe Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.4 Eastern Europe Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.5 Eastern Europe Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.6 Eastern Europe Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.7 Russia Market
    • 21.7.1 Russia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 21.7.2 Russia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 21.7.3 Russia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 21.7.4 Russia Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

22 Middle East Market

  • 22.1 Middle East Market Summary
  • 22.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 22.3 Middle East Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.4 Middle East Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.5 Middle East Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.6 Middle East Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

23 Africa Market

  • 23.1 Africa Market Summary
  • 23.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 23.3 Africa Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Recombinant Protein Material Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 23.4 Africa Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Material Form, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 23.5 Africa Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Processing And Manufacturing Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 23.6 Africa Recombinant Protein-Based Biomaterials Market For Medical Devices Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

24 Competitive Landscape And Company Profiles

  • 24.1 Recombinant Protein-Based Biomaterials Market For Medical Devices Market Competitive Landscape And & Market Share 2024
    • 24.1.1 Top 10 Companies (Ranked by revenue/share)
  • 24.2 Company Profiles
  • 24.3 HTL Biotechnology (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 24.4 Jellagen Ltd (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 24.5 3D BioFibR Inc (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 24.6 Creative Biomart Inc (Company Overview, Products and Services, Financial Overview)
  • 24.7 Collagen Solutions Plc (Company Overview, Products and Services, Financial Overview)

25 Other Major And Innovative Companies

  • 25.1 Advanced BioMatrix Inc (Company Overview, Products and Services)
  • 25.2 Zhuhai Gene-Biocon Biological Technology Co., Ltd (Company Overview, Products and Services)
  • 25.3 Jland Biotech (Company Overview, Products and Services)
  • 25.4 CollPlant Biotechnologies Ltd (Company Overview, Products and Services)

26 Competitive Dashboard

27 Recombinant Protein-Based Biomaterials Market For Medical Devices Market - Company Scoring Matrix

  • 27.1 Innovation & Brand Leaders
  • 27.2 Brand-Driven Traditionalists
  • 27.3 Niche or Regional Followers
  • 27.4 Emerging Innovators

28 Upcoming Startups In the Recombinant Protein-Based Biomaterials Market For Medical Devices Market

29 Key Mergers And Acquisitions

  • 29.1 RTI Surgical Acquired Collagen Solutions

30 Recent Developments In The Recombinant Protein-Based Biomaterials Market For Medical Devices Market

  • 30.1 Positive Non-Clinical Results To Advance Recombinant Collagen-Based Regenerative Biomaterial Development
  • 30.2 Adoption Of Recombinant Protein Cross-Linking Technologies To Enhance Biomaterial Performance

31 Opportunities And Strategies

  • 31.1 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market In 2030 - Countries Offering Most New Opportunities
  • 31.2 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market In 2030 - Segments Offering Most New Opportunities
  • 31.3 Global Recombinant Protein-Based Biomaterials Market For Medical Devices Market In 2029 - Growth Strategies
    • 31.3.1 Market Trend Based Strategies
    • 31.3.2 Competitor Strategies

32 Recombinant Protein-Based Biomaterials Market for Medical Devices Market, Conclusions And Recommendations

  • 32.1 Conclusions
  • 32.2 Recommendations
    • 32.2.1 Product
    • 32.2.2 Place
    • 32.2.3 Price
    • 32.2.4 Promotion
    • 32.2.5 People

33 Appendix

  • 33.1 Geographies Covered
  • 33.2 Market Data Sources
  • 33.3 Research Methodology
  • 33.4 Currencies
  • 33.5 The Business Research Company
  • 33.6 Copyright and Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기